Ensysce Biosciences (ENSC) Price to Book (2018 - 2025)

Ensysce Biosciences (ENSC) has reported Price to Book for 8 consecutive years, with 0.73 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Price to Book fell 56.43% year-over-year to 0.73 in Q4 2025; TTM through Dec 2025 was 0.73, a 56.43% decrease from a year earlier, with the FY2025 full-year figure at 0.01, down 58.57% from the prior year.
• Price to Book was 0.73 for Q4 2025 at Ensysce Biosciences, down from 6.27 in the prior quarter.
• Over five years, Price to Book peaked at 30.72 in Q1 2022 and troughed at 190.76 in Q3 2021.
• A 5-year average of 11.82 and a median of 1.0 in 2025 frame the typical range for Price to Book.
• Across the five-year window, Price to Book slumped 2593.73% in 2022 and soared 8891.96% in 2023, its largest moves.
• Over 5 years, Price to Book stood at 11.62 in 2021, then jumped by 96.54% to 0.4 in 2022, then sank by 816.97% to 3.69 in 2023, then jumped by 145.6% to 1.68 in 2024, then slumped by 56.43% to 0.73 in 2025.
• The last three Price to Book figures came in at 0.73 (Q4 2025), 6.27 (Q3 2025), and 1.74 (Q2 2025), per Business Quant data.